
|Articles|February 15, 2004
Scleral spacing procedure study to begin
The FDA has approved Refocus Group's request to begin phase II clinical trials of its scleral implants and scleral spacing procedure for the surgical treatment of presbyopia.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Laru-zova meets primary endpoint in pivotal VISTA trial for X-linked retinitis pigmentosa
2
EyeCon 2026: ODs and MDs pull up a chair
3
Addressing geographic variation in dry eye disease care requires patient-centric approaches
4
How screen time and eyelid health affect dry eye risk
5











